Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2021-08-04

Original market date: See footnote 1

2021-08-04

Product name:

ILUMYA

Description:

SINGLE-DOSE PREFILLED SYRINGE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02516098

Product Monograph/Veterinary Labelling:

Date: 2021-05-19 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

SUN PHARMA GLOBAL FZE
OFFICE 43  Block Y Saif Zone
Sharjah
--
United Arab Emirates

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Prescription,  Schedule D  

American Hospital Formulary Service (AHFS): See footnote 3

84:92.00   MISC. SKIN AND MUCOUS MEMBRANE AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

L04AC17  TILDRAKIZUMAB

Active ingredient group (AIG) number:See footnote 5

0162907001

List of active ingredient(s)
Active ingredient(s) Strength
TILDRAKIZUMAB 100 MG / 1 ML

Application information

Related information

Contact us

Version 3.9.1
Date modified: